Sponsor or institution
Clinical trials and research at Affiliated Hospital of Jiangsu University
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Affiliated Hospital of Jiangsu University that are recruiting, in China. By phase: Early Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Allogeneic CD19/BCMA CAR-T for relapsed or refractory B-cell and plasma cell cancers
This study will test whether an off-the-shelf CAR-T product (RN1101) that targets CD19 and BCMA can help people with relapsed or refractory B-cell lymphomas and multiple myeloma.
-
Using CAR NK cells to treat autoimmune diseases
This study is testing a new treatment using special immune cells to see if it can help people with tough autoimmune diseases related to B-cells feel better.
Quick answers
How many clinical trials run by Affiliated Hospital of Jiangsu University are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.